which can be induced by a variety of stimuli; these include bacterial endotoxins (2-5), soluble immune complexes (6-lo), antibody-coated erythrocyte and antibody-coated latex particle complexes ( 1 1, 12), lectins (13, 14), lymphokines (15, 16), and viruses (17). Antigen-specific monocyte procoagulant responses have been shown to be enhanced by the collaborative participation of T lymphocytes via both lymphokine and T cell contact pathways of induction (1 8-24). Serum and platelets enhance the response to endotoxins (25, 26). The activated complement components C3b and C5 can also induce T F synthesis (27) , and exposure of monocytes to low pH causes T F to become available on the cell surface (28). The assembly of the factor X-activating activity on the monocyte surface is enhanced by the endogenous production of factor VII by human monocytes (29) . In the clinical setting (34), increased monocyte T F activity has been demonstrated using coagulation assay methods after splenectomy in trauma patients (35), after other surgical procedures (36), and in individuals with Mediterranean fever (37), rheumatic disease and circulating soluble immune complexes (38), bacterial endocarditis (39), or meningococcal infection (40).
Although monocytes taken from pregnant women in the 3rd trimester have been shown to contain less thromboplastin activity and to generate less activity after endotoxin stimulation than those from a control group of nonpregnant women (41), the monocytes of neonates, on endotoxin stimulation, generate amounts of activity similar to those of normal adults when measurements are made on cell suspensions containing similar monocyte concentrations. Comparisons of intracellular thromboplastin activity of endotoxin-stimulated monocytes from neonates and from adults have not been reported.
In this study, circumstances arising in young babies under which surface monocyte TFA might be expressed were investigated. Particular interest was taken in babies being screened for the presence of infection. Monocytes were examined for the expression of surface TFA using a fluorescent antibody technique, the results being compared with measurements of T F expression on monocytes from a group of noninfected infants. MATERIALS were studied for the presence of tissue antigen expression. The first comprised babies born by elective cesarean section who were studied at birth (group 1, n = 4) and babies born vaginally in the absence of any evidence of previous or intercurrent infection (group 11, n = 9; ages at day of study, 3-76 d); the second population included infants in whom risk factors for infection existed at birth or in whom there were nonspecific clinical signs such as tachypnea or apneic episodes, which can be associated with infection. In some, a diagnosis of infection was confirmed (group 111, n = 10); in others, the diagnosis, although suspected clinically, was not proven (group IV, n = 13). Four babies in whom infection had been proven previously were studied beyond the immediate period of their infection (5-25 d) to obtain information on the possible duration of monocyte TFA expression.
Blood samples (0.25 mL) were withdrawn from saline-flushed arterial catheters or by direct venipuncture of the umbilical vein at delivery or from a peripheral vein after Betadine (Napp Laboratories, Cambridge, UK) surface cleansing. The study as conducted had the approval of the Hospital District Ethics Committee, although repeat studies during a suspected infection were not approved and therefore could not be performed. The permitted sample volume was 0.25-0.3 mL.
Infection screening of iizfant population. All infants, with the exception of the four who were studied after infection episodes, were evaluated for evidence of bacterial infection before any antimicrobial administration, although in two instances the babies' mothers had received i.v. antimicrobials before delivery and within 24 h of the screening of the newborn infants. Investigations used in support of the categorization "infected" were a C- These included babies developing increasingly frequent apneic episodes "of prematurity" and babies with tachypnea in association with one or more of the following: meconium aspiration, delayed clearance of fetal lung fluid, surfactant deficient respiratory distress syndrome, and congenital heart disease. Statistical methods. The nonparametric Mann-Whitney U test was applied to the results obtained for the group with proven infection and to the results from those with no evidence of infection. TFA antibodj): antigen pur$cation. Heptanelbutanol powders of human brain frozen at -70°C for less than 6 mo were produced according to the procedures of Nemerson (42) . Two g of these powders were dissolved in 25 mL of 1.250% DOC (43) in veronal buffer (2.2 g barbital, 14.0 g Na barbital in 4 L), pH 8.6 (44) . The product was centrifuged to remove coarse material (17 600 x g for 30 min) and recentrifuged to clarify. The supernatant was then adjusted to pH 9.6 with 1 M NaOH. Gelfiltration. The supernatant from the heptanelbutanol powders was applied to a Sephacryl S-300 superfine gel filtration column (Pharmacia 60 x 2.5 cm; Pharmacia LKB Biotechnology AB, Uppsala, Sweden) and was eluted with 0.625% DOC in veronal pH 8.6 at a rate of 15 mL/h. Four-mL fractions were collected and assayed for T F procoagulant activity (28) . Preparative IEF. Biologically active fractions from the gel filtration were combined and prepared for IEF by dialyzing against 0.2% Triton X-100 (Sigma Chemical Co., St. Louis, MO) to remove the DOC. The IEF was performed on agarose gels (Ultrodex, LKB) in the pH range 5-8 (Ampholine, LKB). After the electrophoresis, the gel was fractionated, the fractions being eluted through small filtration columns with 0.625% DOC in veronal buffer. The fractions were then passed through a short desalting column (25 x 2.5 cm) to remove ampholytes. Samples drawn from the fractions were relipidated to reconstitute activity before assaying for T F procoagulant activity. The active fractions were subjected to affinity chromatography using anti-human antiserum (Behring Diagnostics, Hoechst UK, Hounslow, UK) coupled to CNBr-activated Sepharose (Pharmacia) (44) to remove any residual contaminating plasma protein traces.
Assay of procoagzllant activity. T F activity was determined by a one-stage unactivated partial thromboplastin time (28) . Relipidation of apoprotein was carried out according to the procedure of Gonmori and Takeda (44) . The nonrelipidated apoprotein was stored in aliquots at -70°C. Antibody prodzlction. Nonrelipidated purified apoprotein was dialyzed against veronal buffer (pH 8.6) and precipitated from solution by addition of ammonium sulfate (final concentration 60% saturation). Three mg of the washed precipitate were redissolved in Freund's complete adjuvant (Difco Ltd., Detroit, MI) and injected into rabbits (New Zealand Whites, 3-4 kg). Further ir~jections of 0.3 mg in adjuvant were given biweekly for 3 mo. The rabbits were bled by direct peripheral arterial cannulation to prevent contamination by rabbit T F into endotoxin-free plastic tubes. Sera were stored at -70°C. The IgG fraction was precipitated (33.3% saturation of ammonium sulfate) and resuspended in veronal bufferlsaline (pH 7.35). The solution was then assayed for biologic inhibitory activity by measuring the degree of procoagulant inactivation produced in a preparation of brain T F (Manchester comparative reagent, human brain origin). The antibody was further purified by affinity chromatography to TFA covalently bound to Sepharose 4B using CNBr (45) . The IgG fraction was passed through a small affinity column (10 mL) and washed with veronal bufferlsaline (pH 7.35). The anti-TF IgG was eluted from the column with 1 M glycine (adjusted to pH 3 with HC1) and was dialyzed against PBS. An Ouchterlony precipitin gel showed lines of identity with the immunizing apoprotein antigen, with brain T F (Manchester reagent), and with T F derived from endotoxin-stimulated monocytes. No precipitin lines were obtained between the anti-TF antibody and normal human plasma. Inhibitory activity of purified antibody was determined by incubating equal volumes of human brain-derived T F (Manchester reagent) diluted 1 in 4000 in veronal buffer with the IgG at 37°C; residual procoagulant activity was assayed in an unactivated partial thromboplastin time (28) . Immunoblot analysis of crude and purified TFA was performed on 12% polyacrylamide gel, transferred to nitrocellulose, and reacted with a 1 in 2 dilution of antibody.
All solutions were endotoxin free as determined by chromogenic limulus assay (limit of sensitivity 0.01 endotoxin units/ mL; Whittaker M. A. Bioproducts, Walkersville, MD) and were prepared and stored in endotoxin-free containers.
Blood collection and mononz~clear cell preparation. Whole blood (0.25 mL) was collected into a 1.5-mL polypropylene microtube (Sarstedt, Numberecht, Germany) containing 0.1 mL Na citrate/citric acid (three parts 0.1 M Na citrate, two parts 0.1 M citric acid) anticoagulant and 0.65 mL normal saline. The 1 mL of saline/blood/anticoagulant was layered onto 0. The antibody recognized a single 53-kD band consistent with the reported size of purified human T F (Fig. 2) on the immunoblot analysis. The gating positions of TF-expressing, newborn-derived monocytes and adult-derived monocytes were similar, and no loss of activity followed storage for 12-24 h in the dark. The pattern of nonspecific second antibody binding is seen in Figure  3 (low level fluorescence) along with the binding to previously coupled anti-TFA antibody on monocytes from a baby with Listeria monocyrogenes infection (high level fluorescence).
The photomicrograph is of a fluorescent antibody-positive monocyte from a baby with coagulase-negative staphylococcal septicemia (Fig. 4) Motlocvte TFA detection. The highest percentage of monocytes expressing TFA as evidenced by their levels of fluorescence in the cord-obtained samples from the group I babies was 24 ( n = 4, values 1 I , 20, 22, and 24%, Fig. 5 , c o l~i n~n I) . Of the group 11 babies, also designated as negative for infection, with the excep- for TFA in the samples from the elective cesarean section babies, cord blood origin (colwrzn I), from babies designated negative for infection (colurnrz II), from babies with proven infection (column III). and from those in which infection was strongly suspected (column 11'). In the latter group, those studied within 4 d of the infection screening tests are represented by .filled circles, and those studied more than 4 d after screening are represented by open circles. In column II, the asterisk marks the result of the monocytes from the baby with isoimmune Rhesus (RhD) blood group incompatibility. tion of one, the highest value was 22% (n = 9, values 37. 22, 19, 12, 10, 4, 3, 2, and 0%; Fig. 5, column II) . The baby in whom 37% of monocytes were positive was affected by Rhesus blood group incompatibility; his erythrocytes were Coombs positive. Two neonates affected by isoimmune anti-A blood group incompatibility and without evidence of infection were studied subsequently. In one, 74%, and in the other, 92% of the analyzed monocytes were positive. In group 111 with proven infection, in which sampling was carried out within 4 d of the positive bacterial/fungal diagnosis (four within 1 d, five within 2 d, and one within 4 d), nine of the 10 had a high percentage of their monocytes strongly positive for TFA. These values are significantly different from those obtained for the babies with no evidence of infection ( p < 0.001). One baby who was blood culture positive for the yeast Candida psez~dotropicalis had no strongly positive monocytes demonstrable from her blood. In a single baby with cytomegalovirus infection, but with a coagulasenegative staphylococcal septicemia, 99% of monocytes were positive (Fig. 5, column III, Table 1 ).
In four babies who had previously been established as infected on the basis of positive bacterial isolates 19, 5, 13, and 25 d before monocyte testing (J, K, L, and M in Table 2 ), the percentage of the monocyte population positive for TFA was 99, 97, 70, and 33, respectively, at a time when each appeared free of infection, the C-reactive protein and band/total neutrophil index having returned to normal or near normal values at the time of monocyte sampling. Prolonged persistence of monocyte TFA surface expression can therefore be seen to occur.
In group IV, the subgroup strongly suspected of being infected, there were 13 babies. They were all symptomatic at the time of infection screening and were studied at a median age of 
DISCUSSION
There are two principal reasons for our interest in quantifying monocyte T F expression in early infancy: the T F pathway of coagulation activation might be an important mechanism in the initiation of the abnormal proteolysis frequently described in neonatal sepsis and in those affected by severe Rhesus blood group incompatibility, and T F detection might prove to be a useful indicator of the presence of infection or endotoxemia in its own right. This is of particular interest in the young infant, where diagnosis is notoriously difficult but where many of the potential stimuli for T F expression are likely to be rarely encountered. Immune complex disorders are one such group that might be anticipated to give rise to monocyte T F expression. IgG-erythrocyte complexes have been shown in vitro to induce monocyte T F expression (1 l), and in vivo induction has also been reported (1 2); their presence may have induced the positivity in the baby with Rhesus IHD and in the babies with anti-A IHD. Another potential complicating factor is the reported frequency of endotoxemia in cord blood at delivery (47). We have not observed percentages of positive monocytes greater than 24% in four cord-derived samples taken at birth from apparently noninfected babies. However, it is possible that this level of monocyte positivity is due to low concentrations of endotoxin, as have been reported.
The possibility of a positive result being an artifact due to in vitro T F elaboration by monocytes is unlikely because, even if monocytes that have been slightly stimulated before sampling were to respond more readily than normal monocytes to low concentrations of endotoxin in vitro, it is improbable that endotoxin levels, which are so low as to be unmeasurable, would produce the high percentages of strongly positive cells observed total preparative phase was completed in less than 5 h from the in the babies with proven infection and lower percentages of time of sampling. strongly positive cells in the baby affected by Rhesus IHD. It is very likely that the four babies studied within 4 d of T F procoagulant activity is not normally demonstrable until infection screening investigations, who were in the group of at least 2 h after endotoxin exposure at 37"C, and the cells in this babies strongly suspected of being infected and in whom high study were kept at 4°C during cell washings, the antibody labeling percentages of monocytes were positive, were in fact infected. being the only procedure carried out at room temperature. The One was recovering from an episode of necrotizing enterocolitis experienced 2 wk previously when he unexpectedly collapsed, requiring ventilatory support. One had been tachypneic from birth for no identified reason, one developed diarrhea and vomiting, and one had been asphyxiated perinatally, was febrile postnatally, had 40 white cells in his cerebrospinal fluid, and made an uneventful recovery with antimicrobial therapy. Confirmation of infection may not have been obtained for several reasons. Cultures for mycoplasmas and ureaplasmas were not routinely performed, and the volume of blood available for culture was sometimes small. Lipoglycans from mycoplasmas can induce mononuclear cell T F procoagulant activity (48) . Viral cultures were not always performed, and, when they were, only a few specific viruses were sought. Antimicrobials administered to the mother before the birth of her baby may have obviated a positive bacterial isolate in two instances.
A wide range of postnatal ages were encountered in the singly studied, noninfected babies in group I1 (2, 3, 5, 6, 8, 9, 14, 46 , and 76 d). The antigen and enteral endotoxin exposures associated with increasing postnatal age do not appear to be sufficient stimuli to cause many of the circulating blood monocytes to express surface T F strongly.
The results from the monocyte testing obtained within 4 d of a positive culture, were considered separately from those obtained beyond 4 d because culture and sequentially performed ancillary infection test results can usefully be evaluated at this time; if monocyte TFA expression were to be used as a predictor of infection, then TFA would have to be detectable within this time frame. If negative, the results of this combination of tests can be of help in deciding whether the infant, started on antimicrobial treatment at the time of initial screening, may reasonably be taken off such treatment; conversely, when infection, although not proven on culture, is strongly suspected on the basis of the ancillary test results, treatment can be continued.
Of interest is the apparent persistence of monocyte positivity after bacterial infections in cases J, K, L, and M. In only one of these babies (case M) was any chronic disease evident; this took the form of chronic lung disease after pneumonia. The remaining three had all made uneventful recoveries at the time of sampling. The negative results In the case of Candida septicemia can be attributed to the lack of previous T-cell sensitization to this antigen in the baby concerned. T-cell sensitization and collaboration appear to be prerequisites for the monocyte procoagulant response to Candida (49) .
This study has demonstrated that a very high percentage of monocytes from preterm infants can express T F to a degree similar to that of monocytes from term infants when either group is infected with gram-positive or gram-negative bacteria. This capacity is present on d I of life and is maintained with increasing maturity (Stuphylococc~u epldermrdls on d 26 in a 25-wk gestation baby, Klebsiella on d 40 in a 32-wk gestation baby). The constraints on permitted blood sampling for this study prevented us from comparing biologic procoagulant activity with TFA expression. An extrinsic pathway inhibitor has been identified in adult serum (50) , and a potent placental inhibitor has been described (51) . What level is present in neonates at differing gestations and how its presence might affect T F procoagulant activity or antigen detection remains to be discovered. Only one of the cases with sepsis and TFA-positive monocytes had coagulation test results that were abnormal for the gestational and postnatal age of the baby; they were compatible with a diagnosis of disordered proteolysis.
From this investigation, it is not possible to make any general statement as to whether viral infections in the neonate induce TFA expression. In only one case of proven viral disease, an acquired infection with two strains of cytomegalovirus (case J), were 99% of the monocytes positive; however, at the time, blood cultures were positive for coagulase-negative staphylococci. Further studies are required during viral infections, although these infections are thought to be rare during the 1st wk of life; information is also required during the course of the more common stressful conditions such as surfactant-deficient respiratory distress syndrome before the value of monocyte T F measurement as an indicator of the presence of infection can be fully evaluated. In conclusion, we have shown that when more than 60% of the blood monocytes of an infant are found to be positive for surface TFA as defined by this method there appears to be a high likelihood of the infant being infected or, by inference, of having biologically significant blood levels of endotoxin.
